Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 2022

View Archived Issues

BLU-945 for treatment-resistant EGFR T790M mutation-driven lung cancer

Medshine Discovery divulges thyroid hormone receptor beta agonists

Galderma discovers JAK-1 inhibitors

New NFE2-related factor 2 activators described by Sanofi

CNRS and collaborators patent acetylcholinesterase reactivators

RemeGen discloses new anti-c-Met antibody-drug conjugates

Telomere to telomere, the human genome is done

Novel humanized HIS-BRGS mouse model to evaluate immune-related kidney toxicities

New orthotopic xenograft breast cancer murine models developed

Humanized mouse model to asses acute toxicity of immune drug treatments

Sosei Heptares presents novel GLP-1 receptor antagonist HTL-0033097

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026